MSFS
ATYR

Main Street Financial Solutions’s aTyr Pharma ATYR Stock Holding History

Main Street Financial Solutions’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-144,950
Closed -$105K – 654
2025
Q3 		$105K Buy
144,950
+1,350
+0.9% +$6.12K 0.01% 584
2025
Q2 		$728K Buy
143,600
+9,350
+7% +$36.8K 0.05% 284
2025
Q1 		$405K Buy
+134,250
New +$490K 0.04% 355
2024
Q4 		– Sell
-66,475
Closed -$117K – 579
2024
Q3 		$117K Sell
66,475
-1,250
-2% -$2.27K 0.01% 511
2024
Q2 		$106K Buy
67,725
+33,250
+96% +$57.9K 0.01% 521
2024
Q1 		$67.2K Buy
+34,475
New +$60.1K 0.01% 501

Other funds holding ATYR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Main Street Financial Solutions's ATYR Position: Q4 2025 in Review

Main Street Financial Solutions sold out of aTyr Pharma (ATYR) in Q4 2025, closing a stake of 144,950 shares — an estimated $105K sold.

Main Street Financial Solutions first reported a position in ATYR in Q1 2024 and held it in 6 quarters. The position peaked at $728K in Q2 2025. 84 funds tracked by Wall St. Rank hold ATYR as of Q4 2025.

  • Main Street Financial Solutions reported no remaining aTyr Pharma position as of Q4 2025 after selling out during the quarter.
  • Main Street Financial Solutions sold 144,950 aTyr Pharma shares in Q4 2025, an estimated $105K.
  • Main Street Financial Solutions first reported a position in aTyr Pharma in Q1 2024 and held it in 6 quarters.
  • Main Street Financial Solutions's aTyr Pharma position peaked at $728K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.